NewEdge Wealth’s Labcorp LH Stock Holding History

NewEdge Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-966	Closed	-$242K	–	1224
2025 Q4	$242K	Buy	+966	New	+$257K	﹤0.01%	1098
2022 Q3	–	Sell	-2,422	Closed	-$488K	–	573
2022 Q2	$488K	Buy	+2,422	New	+$516K	0.02%	396

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NewEdge Wealth's LH Position: Q1 2026 in Review

NewEdge Wealth sold out of Labcorp (LH) in Q1 2026, closing a stake of 966 shares — an estimated $242K sold.

NewEdge Wealth first reported a position in LH in Q2 2022 and held it in 2 quarters. The position peaked at $488K in Q2 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

NewEdge Wealth reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
NewEdge Wealth sold 966 Labcorp shares in Q1 2026, an estimated $242K.
NewEdge Wealth first reported a position in Labcorp in Q2 2022 and held it in 2 quarters.
NewEdge Wealth's Labcorp position peaked at $488K in Q2 2022.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.